Intellectual Property
Pivotal to the development and commercialisation of the Prima BioMed product portfolio is strong intellectual property protection for the underlying technology and product opportunities. Prima has secured, under license from the Burnet Institute, five patent families at various stages of prosecution. These patents are being prosecuted worldwide in the major market jurisdictions to maximise market coverage and underpin future incomes from licensing.
As of January 2011 the patent portfolio under management contains 39 granted patents and 15 applications under prosecution.
Current advice on patents and intellectual property is managed by patent counsel at Davies Collison Cave in Melbourne.
|
|